|
|||||||||||||
|
|
||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||
|
|
Dermatopharmacology at NYU The Dermatopharmacology Unit of the Ronald O. Perelman Department of Dermatology is located in the Charles C. Harris Skin and Cancer Pavilion at the New York University Medical Center. Established in the 1970s, the Unit has developed into one of the nation's largest and most distinguished clinical research centers in dermatology. Our mission is to advance the understanding of inflammatory skin disease through patient care, clinical research, and translational studies. The Unit is primarily responsible for carrying out industry-sponsored clinical trials relating to skin disease such as psoriasis, cutaneous t-cell lymphoma, pemphigus vulgaris, and acne vulgaris. The unit is also involved in investigator initiated studies addressing new therapies for a variety of skin diseases. The Dermatopharmacology Unit is currently under the direction of Bruce Strober, M.D., Ph.D. and Jerome Shupack M.D., both full-time members of the academic faculty at the New York University School of Medicine. Our staff includes one clinical M.D. fellow, one clinical research nurse and two study coordinators. We are currently
enrolling patients for the following studies:
If you would like to be contacted in order to receive consideration for the above listed clinical trials or future clinical trials, please call 212-263-6881 or e-mail Judy Wang at dermpharm@med.nyu.edu.
|
||||||||||||||||||||||||||||||||||||||
| NYU Langone Medical Center | NYU School of Medicine | Research at NYU | Administration | NYU Hospital
for Joint Diseases | Giving & Support © 2008 NYU Langone Medical Center | For Trustees | Ethics | Disclaimer | Privacy Policy | Sitemap |
Contact Webmaster
|